Skip to main content
Overview
Press Releases
Events & Presentations
Stock Info
Stock Quote
Stock Chart
Historical Stock Quote
Analyst Coverage
Financials
Quarterly Results
Annual Reports
SEDAR Filings
Governance
Executive Management
Board of Directors
Committee Composition
Governance Documents
Resources
Investor FAQs
Request Info
Investor Email Alerts
Skip to main content
Menu
Home
About
Duchenne
Science
Overview
Our Approach
MyoReGenX™ Platform
Presentations & Publications
Patients
Investors
Overview
Press Releases
Events & Presentations
Stock Info
Stock Quote
Stock Chart
Historical Stock Quote
Analyst Coverage
Financials
Quarterly Results
Annual Reports
SEDAR Filings
Governance
Executive Management
Board of Directors
Committee Composition
Governance Documents
Resources
Investor FAQs
Request Info
Investor Email Alerts
Careers
Contact
About
Duchenne
Science
Patients
Overview
Our Approach
MyoReGenX™ Platform
Presentations & Publications
Investors
Overview
Press Releases
Events & Presentations
Stock Info
Stock Quote
Stock Chart
Historical Stock Quote
Analyst Coverage
Financials
Quarterly Results
Annual Reports
SEDAR Filings
Governance
Executive Management
Board of Directors
Committee Composition
Governance Documents
Resources
Investor FAQs
Request Info
Investor Email Alerts
Careers
Contact
Event Details
Overview
Press Releases
Events & Presentations
Stock Info
Stock Quote
Stock Chart
Historical Stock Quote
Analyst Coverage
Financials
Quarterly Results
Annual Reports
SEDAR Filings
Governance
Executive Management
Board of Directors
Committee Composition
Governance Documents
Resources
Investor FAQs
Request Info
Investor Email Alerts
Satellos Bioscience Phase 2 TRAILHEAD Data Interim Readout
July 8, 2026
Webcast
(opens in new window)
Presentation
(opens in new window)
Dial-in information:
Domestic:
1-877-269-7751
International:
1-201-389-0908
Conference ID:
13761409